Kenneth R. McBean

Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.

Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC.

Covidien Holding, Inc. manufactures and supplies healthcare products for use in clinical and home settings. It offers medical devices, pharmaceuticals and medical supplies to hospitals, long-term care and alternate care facilities, doctors’ offices and in the home. The company is headquartered in Minneapolis, MN.

Alfasigma USA, Inc. is a specialty biomedical company that specializes in personalized medicine by offering healthcare providers high quality prescription medical foods to address the distinct nutritional requirements of patients suffering from medical conditions. Its brands include VSL#3, METANX, Zelnorm, deplin, CerefolinNAC, Proxeed Plus, and NeevoDHA. The company is headquartered in Covington, LA.